Clobetasol
Clobetasol propionate eye drops for postoperative inflammation, pain now available in US
Clobetasol propionate ophthalmic suspension 0.05% for postoperative inflammation and pain after ocular surgery is now commercially available in the U.S., according to a press release from Eyenovia.
Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain
The FDA approved clobetasol propionate ophthalmic suspension 0.05% for the treatment of inflammation and pain after ocular surgery, according to a press release from Formosa Pharmaceuticals and AimMax Therapeutics.
Salvat submits NDA for clobetasol nanoemulsion to treat ocular surgery inflammation, pain
Salvat Laboratories has submitted a new drug application to the FDA for clobetasol nanoemulsion to treat inflammation and pain after ocular surgery.
Dermatology pearls: Encourage sun protection, optimize steroids for cutaneous lupus
SAN DIEGO — While encouraging patients with cutaneous lupus erythematosus to use adequate sun protection, rheumatologists should be treating disease flares with more potent steroids then tapering off once other therapies are in progress, according to a presentation at the 2019 Congress of Clinical Rheumatology West.